Millet, Bruno

Subthalamic nucleus stimulation in severe obsessive-compulsive disorder

Mallet, L., Polosan, M., Jaafari, N., Baup, N., Welter, M.-L., Fontaine, D., Montcel, S. T. D., Yelnik, J., Chéreau, I., Arbus, C., et al. (2008) · New England Journal of Medicine

Obsessive-Compulsive Spectrum DisordersNeurological disorders and treatments

Cited by 965

Increased exonic de novo mutation rate in individuals with schizophrenia

Girard, S. L., Gauthier, J., Noreau, A., Xiong, L., Zhou, S., Jouan, L., Dionne-Laporte, A., Spiegelman, D., Henrion, E., Diallo, O., et al. (2011) · Nature Genetics

Schizophrenia research and treatmentGenomic variations and chromosomal abnormalities

Cited by 438

Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia

Tarabeux, J., Kebir, O., Gauthier, J., Hamdan, F. F., Xiong, L., Piton, A., Spiegelman, D., Henrion, É., Millet, B., S2D team, et al. (2011) · Translational Psychiatry

Genetics and Neurodevelopmental DisordersSchizophrenia research and treatment

Cited by 231

COVID‐19‐related encephalopathy: a case series with brain FDG‐positron‐emission tomography/computed tomography findings

Delorme, C., Paccoud, O., Kas, A., Hesters, A., Bombois, S., Shambrook, P., Boullet, A., Doukhi, D., Le Guennec, L., Godefroy, N., et al. (2020) · European Journal of Neurology

Long-Term Effects of COVID-19Infectious Encephalopathies and Encephalitis

Cited by 173

Prevalence of smoking in psychiatric patients

Poirier, M.-F., Canceil, O., Baylé, F., Millet, B., Bourdel, M.-C., Moatti, C., Olié, J.-P., & Attar-Lévy, D. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry

Smoking Behavior and CessationSubstance Abuse Treatment and Outcomes

Cited by 150

Admixture analysis of age at onset in obsessive–compulsive disorder

DELORME, R., GOLMARD, J.-L., CHABANE, N., MILLET, B., KREBS, M.-O., MOUREN-SIMEONI, M. C., & LEBOYER, M. (2005) · Psychological Medicine

Obsessive-Compulsive Spectrum DisordersAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 132

Decrease of prefrontal metabolism after subthalamic stimulation in obsessive-compulsive disorder: a positron emission tomography study

Le Jeune, F., Vérin, M., N'Diaye, K., Drapier, D., Leray, E., Du Montcel, S. T., Baup, N., Pelissolo, A., Polosan, M., Mallet, L., et al. (2010) · Biological Psychiatry

Obsessive-Compulsive Spectrum DisordersNeurological disorders and treatments

Cited by 116

Limbic versus cognitive target for deep brain stimulation in treatment-resistant depression: accumbens more promising than caudate

Millet, B., Jaafari, N., Polosan, M., Baup, N., Giordana, B., Haegelen, C., Chabardes, S., Fontaine, D., Devaux, B., Yelnik, J., et al. (2014) · European Neuropsychopharmacology

Neurological disorders and treatmentsObsessive-Compulsive Spectrum Disorders

Cited by 77

Major depressive disorder skews the recognition of emotional prosody

Péron, J., El Tamer, S., Grandjean, D., Leray, E., Travers, D., Drapier, D., Vérin, M., & Millet, B. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesTreatment of Major Depression

Cited by 73

High treatment resistance is associated with lower performance in the Stroop test in patients with obsessive–compulsive disorder

Doolub, D., Vibert, N., Botta, F., Razmkon, A., Bouquet, C., Wassouf, I., Millet, B., Harika-Germaneau, G., & Jaafari, N. (2023) · Frontiers in Psychiatry

Obsessive-Compulsive Spectrum DisordersAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 7